Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kenneth Cusi
University of Florida, Department: Md Endocrinology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Poxel
I am being asked to give a lecture on what is known about current and future treatments in the fields of diabetes an NAFLD and how related existing/in development pharmacological agents compare in terms of efficacy and safety. All slides are of my personal choice and creation, and not subject to their prior approval to use. It does not involve creating IP (???explain why/why not???) because I am providing just my personal opinion as an opinion leader in the field about existing/in development pharmacological agents and the potential for success (or not) of their novel drug PXL065 (not FDA approved but purchased from another company).
It will take place in Boston, MA on 2/8/2019 - Friday afternoon (4 hours).
Filed on February 06, 2019.
Tell us what you know about Kenneth Cusi's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Kenneth Cusi”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kenneth Cusi | University of Florida | Financial Disclosure | Novo Nordisk | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Prosciento | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Janssen Pharmaceutical | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Chronic Liver Disease Foundation | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Allergan, Inc. | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Novo Nordisk | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Bristol-Myers Squibb Company (BMS) | |
| Kenneth Cusi | University of Florida | Financial Disclosure | DeuteRx | |
| Kenneth Cusi | University of Florida | Financial Disclosure | Merck |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.